Related Experiment Video
Updated: Jun 10, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Menopause, hormone replacement and gynaecological cancers
1Belfast City Hospital, Northern Ireland. hindslynsey@hotmail.co.uk
Menopause International
|August 24, 2010
Summary
Hormone replacement therapy (HRT) is generally safe for most women with gynecological cancer, improving quality of life without harming survival rates. It is only contraindicated in specific rare tumors, allowing wider patient access.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
- Clinical Oncology
Background:
- Gynecological cancers affect approximately 18,000 UK women annually.
- Risk factors include early menarche, late menopause, and HRT use.
- Cancer treatments can induce severe iatrogenic menopause, impacting quality of life.
Purpose of the Study:
- To evaluate the safety and efficacy of hormone replacement therapy (HRT) in patients with gynecological cancer.
- To address the controversy surrounding HRT use due to theoretical risks of stimulating residual cancer cells.
Main Methods:
- Systematic review of existing evidence on HRT use in gynecological cancer survivors.
- Analysis of studies examining the impact of HRT on survival and symptom management.
Main Results:
- Evidence does not support the hypothesis that HRT stimulates residual cancer cells in most gynecological cancers.
- No detrimental effect on survival was found for HRT in early-stage endometrial, epithelial ovarian, cervical, and vulval cancers.
- HRT is an absolute contraindication only for low-grade endometrial stromal sarcomas and granulosa cell ovarian tumors.
Conclusions:
- HRT should not be withheld from the majority of patients with gynecological cancer experiencing menopausal symptoms.
- Informed decision-making regarding HRT should involve counseling on risks and benefits for quality of life improvement.
- Further research may clarify HRT's role in specific gynecological cancer subtypes.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...